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The National Comprehensive Cancer Network recommends conservative follow-up for gastric gastrointestinal
stromal tumors (GISTs) less than 2 cm. We have previously reported that the mitotic index of 22.22% of small
gastric GISTs exceeded 5 per 50 high-power fields and recommended that all small gastric GISTs should be
resected once diagnosed. The aim of the present study is to compare the safety and outcomes of endoscopic and
open resection of small gastric GISTs. From May 2010 to March 2014, a total of 90 small gastric GIST patients
were enrolled in the present study, including 40 patients who underwent surgical resection and 50 patients who
underwent endoscopic resection. The clinicopathological characteristics, resection-related factors, and clinical
outcomes were recorded and analyzed. The clinicopathological characteristics were comparable between the two
groups except for tumor location and DOG-1 expression. Compared with the surgical resection group, the
operation time was shorter (P= .000), blood loss was less (P= .000), pain intensity was lower (P b .05), duration of
first flatus and defecation was shorter (P b .05), and medical cost of hospitalization was lower (P = .027) in the
endoscopic resection group. The complications and postoperative hospital stay were comparable between the
two groups. No in situ recurrence or liver metastasis was observed during follow-up. Endoscopic resection of
small gastric GISTs is safe and feasible compared with surgical resection, although perforation could not be totally
avoided during and after resection. The clinical outcome of endoscopic resection is also favorable.
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Gastrointestinal stromal tumors (GISTs) are the most common
mesenchymal tumor of the gastrointestinal tract [1] and are believed
to originate from the interstitial cells of Cajal, the pacemaker cells of
the gastrointestinal tract [2]. GISTs can occur anywhere throughout
the gastrointestinal tract; the most common locations are the
stomach, small intestine, duodenum, and colorectum. Rare cases
have been reported out of the gastrointestinal tract [3].
According to the National Comprehensive Cancer Network
guideline [4], gastric GISTs less than 2 cm and with a mitotic
index less than 5 per 50 high-power fields (HPF) are considered as
very low risk, and conservative follow-up is suggested for small gastric
GISTs [5]. However, it is believed that small gastric GISTs also have
malignant potential, and we have previously reported that the mitotic
index of 14 out of 63 small gastric GISTs (22.22%) exceeded 5 per 50
HPF [6]. Moreover, it was reported that the size of small gastric
GISTs increased significantly during follow-up [7], and one case ofsmall gastric GIST showed rapid growth and early metastasis to
the liver [8].
Given this situation, we proposed that small gastric GISTs should
be resected immediately once diagnosed. However, little is known
about the safety and clinical outcomes between endoscopic resection
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was carried out to investigate the safety and clinical outcomes of
endoscopic resection in comparison to surgical resection for small
gastric GISTs.
Materials and Methods
Patients
This study was performed in the Xijing Hospital of Digestive
Diseases affiliated to the Fourth Military Medical University. From
May 2010 to March 2014, a total of 90 patients were enrolled in the
present study, including 40 small gastric GIST patients who
underwent surgical resection and 50 small gastric GIST patients
who underwent endoscopic resection. This study was approved by theFigure 1. Endoscopic and surgical resection of small gastric GISTs
pattern. (B) Endoscopic resection of small gastric GIST. (C) Gastric per
closed with clips after endoscopic resection. (E and F) Surgical resecEthics Committee of Xijing Hospital, and written informed consent
was obtained from all patients before surgical or endoscopic resection.
Resection Procedures
For the surgical resection group, all patients received general
anesthesia with tracheal intubation. The procedure started with a
traditional left side transrectus upper abdominal incision. The incisal
margin was 2 cm beyond the tumor margin, and frozen slices of the
incisal margin were performed during surgery. The detailed operation
method depended on the location of tumor. For the endoscopic
resection group, all patients received intravenous anesthesia. Marking
dots were made with hook knife 3 mm outside the tumor margin. A
10% glycerin solution containing epinephrine (0.005 mg/ml) was
injected into the submucosal layer. The tumor was completely. (A) Endoscopic view of small gastric GIST with intragastric type
foration occurred during endoscopic resection. (D) Perforation was
tion of small gastric GISTs.
Table 1. Comparison of Clinicopathological Characteristics between Two Groups
Characteristics Surgical Resection Endoscopic Resection P Value
Age (years)
≤60 18 28 .300
N60 22 22
Gender
Male 25 24 .170
Female 15 26
Tumor location
Cardia 4 4 .018
Fundus 9 27
Body 23 17
Antrum 4 2
Tumor ulceration
Yes 8 2 .021
No 32 48
Tumor bleeding
Yes 2 0 .195
No 38 50
Tumor margin
Regular/smooth 37 48 .652
Irregular 3 2
Growth type
Intracavity 38 50 .195
Extracavity 2 0
Histological type
Spindle 40 50 –
Epithelioid 0 0
Mixed 0 0
Intratumoral bleeding
Yes 1 0 .444
No 39 50
Intratumoral necrosis
Yes 1 0 .444
No 39 50
Mitotic index
≤5 31 41 .596
N5 9 9
Ki-67
≤5 37 46 1.000
N5 3 4
CD117
Positive 38 50 .195
Negative 2 0
CD34
Positive 38 50 .195
Negative 2 0
DOG-1
Positive 34 50 .006
Negative 6 0
Table 2. Comparison of Perioperative Characteristics between Two Groups.
Characteristics Surgical Resection Endoscopic Resection P Value
Operation time (min) 113.60 ± 14.02 50.00 ± 4.96 .000
Blood loss (ml) 56.67 ± 9.77 2.96 ± 0.48 .000
First flatus 62.43 ± 7.67 42.29 ± 5.27 .034
First defecation 78.37 ± 9.48 53.06 ± 6.28 .029
Postoperative hospital stay (day) 5.87 ± 0.29 5.80 ± 0.30 .883
Medical cost of hospitalization (RMB) 32600.39 ± 2267.51 27210.46 ± 869.62 .027
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and squeezed out of the gastric wall without rupture. Clips were used
to close the incision to avoid bleeding and perforation. All the
endoscopic resections and surgical resections were performed by
skilled doctors (Figure 1).
Pathology
All the specimens after surgical or endoscopic resection were
treated routinely for histologic examination in the Pathology
Department in the Xijing Hospital of digestive diseases. Histological
type and mitotic index were detected by hematoxylin and eosin stain.
Immunohistochemistry was performed on 3-μm sections according
to the manufacturer's instructions and the following antibodies:
CD117, CD34, DOG-1, and Ki67.
Follow-Up
The patients after resection were followed up through endoscopic
ultrasound and computed tomography every 6 months to evaluate
tumor recurrence and distant metastasis.
Data Collection
We recorded the preoperative data including age, gender, tumor
location, tumor ulceration, tumor bleeding, tumor margin, growth type,
and tumor size. The pathological characteristics including histological
type, intratumoral bleeding, intratumoral necrosis, mitotic index, Ki-67,
CD117, CD34, and DOG-1 were also recorded. The surgical and
endoscopic resection–related data including operation time, blood loss,
first flatus, first defecation, pain intensity, postoperative hospital stay,
medical cost of hospitalization, and postoperative complications were also
recorded. Pain intensity was evaluated frompostoperative day (POD) 1 to
POD 3 using a visual analog scale.
Statistical Analysis
Data were processed using SPSS 16.0 for Windows (SPSS Inc.,
Chicago, IL). Numerical variables were expressed as the mean ± SD
unless otherwise stated. Discrete variables were analyzed using the
chi-square test or Fisher's exact test. The P values were considered to
be statistically significant at the 5% level.
Results
The clinical and pathological characteristics were comparable between
the two groups except for tumor location and DOG-1 expression
(Table 1). Compared with the surgical resection group, the operation
time was shorter (113.60 ± 14.02 vs 50.00 ± 4.96 minutes, P = .000),
blood loss was less (56.67 ± 9.77 vs 2.96 ± 0.48 ml, P = .000), and
medical cost of hospitalization was lower (32,600.39 ± 2267.51¥ vs
27,210.46 ± 869.62¥, P = .027) in the endoscopic resection group.
The patients in the endoscopic resection group also showed
significantly accelerated recovery of gastrointestinal function in
terms of time to first flatus and first defecation (P b .05).The
postoperative hospital stay was comparable between the two groups
(Table 2). Visual analog scale analysis showed that pain intensity of
patients in the endoscopic resection group was significantly lower
than that of patients in the surgical resection group on POD 1 to 3
(P b .05) (Table 3).
The overall complication rate in the surgical resection group was
5.00% compared with 12% in the endoscopic resection group (P =
.292). In the surgical resection group, two patients (5.00%) suffered
from pneumonia. In the endoscopic resection group, three patients
(6.00%) experienced perforation and suffered from fever afterresection; the fever of two patients was controlled by antibiotics,
and the remaining patient underwent reoperation because of
abdominal infection. One patient (2.00%) in the endoscopic
resection group experienced tardive postoperative hemorrhage 1
month after resection, and the hemorrhage was controlled by
conservative treatment (Table 4). All the patients after surgical
resection and endoscopic resection were followed up using
endoscopic ultrasound and abdominal computed tomographic
able 3. Comparison of Postoperative Pain Intensity between Two Groups
ime Surgical Resection Endoscopic Resection P Value
OD1 3.154 ± 0.154 0.551 ± 0.131 b .001
OD2 1.941 ± 0.135 0.184 ± 0.063 b .001
OD3 1.231 ± 0.122 0.102 ± 0.044 b .001
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Pexamination. The median follow-up time was 32 months (range from
12 to 65 months), and no in situ recurrence or liver metastasis was
observed during follow-up.
Discussion
The aim of the present study was to evaluate the safety and clinical
outcomes of endoscopic resection of small gastric GISTs in
comparison with conventional surgical resection. The data of the
present study showed that the endoscopic resection group had shorter
operation time, less intraoperative blood loss, shorter time to first
flatus and defecation, lower postoperative pain intensity, and lower
cost of hospitalization. The complications in the two groups are
comparable, and no recurrence and distant metastasis were observed
in the endoscopic resection group.
The National Comprehensive Cancer Network recommends that
small gastric GISTs less than 2 cm can be conservatively followed up
[9]. However, every GIST is now regarded as potentially malignant,
including small gastric GISTs. It was reported that the tumor size of
small gastric GISTs could increase significantly during follow-up
[10], and our previous study showed that the mitotic index of
approximately 22.22% of small gastric GISTs exceed 5 mitotic figures
per 50 HPF [6]. This highlights the fact that even if the gastric GIST
is small, the tumor could show rapid growth, potential for metastasis,
and poor prognosis. Thus, resection of small gastric GIST should be
taken into consideration once diagnosed.
Up to now, surgery is the main treatment of GISTs, and complete
surgical resection with an adequate margin and without rupture and
spillage remains the definitive treatment for gastric GISTs [11]. As
lymphatic metastasis is rare in gastric GISTs and with the rapid
advances in the development of minimally invasive technology and
endoscopic skill, there are more choices for treatment of local GISTs,
including laparoscopic resection [12], endoscopic resection [13], and
combination of laparoscopic and endoscopic resection [14]. Previ-
ously, it was thought that endoscopic resection was not appropriate
for GIST considering that GIST originated from the muscular layer.
However, endoscopic resection of GIST has been accepted for its
satisfied safety and outcome [15]. Compared with surgical resection,
endoscopic resection has many advantages, such as an intact stomach
after resection, a relatively short postoperative hospital stay, aTable 4. Comparison of Postoperative Complications between Two Groups
Surgical Resection Endoscopic Resection P Value
Total cases 2 6 .292
Pneumonia 2 0 .195
Abdominal infection 0 1 1.000
Gastric retention 0 0
Perforation and fever 0 3 .251
Postoperative hemorrhage 0 1 1.000
Deep-vein thrombosis 0 0
Ileus 0 0
R1 resection 0 0
Reoperation 0 1 1.000
Mortality 0 0relatively low cost of hospitalization, and fewer human resources
required [16]. Moreover, endoscopic resection has more advantages
for elderly patients and patients who could not tolerate surgical
resection or patients with small size tumors. In our present study, the
endoscopic resection group had shorter operation time, less blood
loss, earlier flatus and defecation, lower pain intensity, and lower
medical cost. However, endoscopic resection remains controversial
because of major complications including perforation and bleeding.
Furthermore, the risk of tumor rupture and spillage and positive
margins is also a huge concern [17].
Perforation is a common and important complication in
endoscopic resection [18]. The direction of tumor growth is one of
the reasons that result in perforation. It was reported that the
perforation rate was 73.68% in extracavity growth type and 18% in
intracavity growth type [19]. The location of the gastric GISTs is
another factor that contributed to perforation. It was reported that the
rate of perforation was higher for the fundus than for other location
[20]. In our present study, intraoperative perforation occurred in 17
patients, which was closed well using titanium clips with no
conversion to open surgery. Only 3 of 17 patients suffered from
fever after endoscopic resection due to application of antibiotics.
Unfortunately, one patient suffered from tardive perforation and
abdominal infection 1 month after endoscopic resection and finally
received open surgery for perforation repair. Perforation is usually
accompanied by pseudocapsule injury, which increases the possibility of
peritoneal seeding, and peritoneal seeding is accompanied by a high
recurrence rate. Waterman et al. reported a case of a patient who
underwent endoscopic resection of small gastric GIST resulting in
incomplete excision and gastric perforation, and the patient had tumor
recurrence in the pelvis 3 years later [21]. However, to date, no
comparative data with surgical resection about long-term follow-up exist.
Bleeding is also a common complication after endoscopic resection,
and severe postoperative bleeding sometimes needs reoperation. In
our present study, one patient after endoscopic resection experienced
tardive postoperative hemorrhage 1 month after resection, and the
hemorrhage was controlled by conservative treatment. R1 resection is
another important issue which should be paid enough attention to.
There have been no data showing whether or not there was remnant
GIST tissue at dissection surface when R1 resection was confirmed
through pathological examination [22]. Although there is no evidence
that patients who have positive microscopic margin require further
resection [23] and several studies have shown that a microscopically
positive margin was not a significant adverse factor [24], one of the
latest studies reported that a 5.8% local recurrence was observed even
though R0 resection was achieved [16]. In our present study with
limited follow-up, no in situ recurrence was observed in patients who
received endoscopic resection.
Small GISTs normally do not recur after surgical removal of tumor,
and the prognosis of small GISTs is generally good [25]. According to
expert consensus, most of the small gastric GISTs are extremely low
risk or low risk based on National Institutes of Health risk factor
classification; therefore, imatinib was unnecessary after resection [26].
Thus, none of the patients in our study were administered with
imatinib after resection, and no in situ recurrence or liver metastasis
was observed with the median follow-up of 32 months. However,
Shen et al. reported that one patient of small gastric GIST after
surgical resection and one patient after endoscopic resection
experienced recurrence or liver metastasis at 23 and 31 months
[27]. It should also be noticed that the exact duration of follow-up is
508 Endoscopic and Open Resection for GIST Feng et al. Translational Oncology Vol. 8, No. 6, 2015uncertain because of the limited existing experience on the
endoscopic resection of small gastric GSITs. A 5-year follow-up
may be appropriate according to surgery follow-up duration.
There are some limitations in the present study. First, it was a
retrospective analysis, and the sample size was not big enough. A
randomized controlled trial should be carried out to evaluate the
safety and prognosis of small gastric GIST patients who underwent
endoscopic resection. Second, the duration of follow-up was not long
enough to evaluate in situ recurrence and liver metastasis. Third, no
patients received adjuvant therapy with imatinib after resection. The
necessity of adjuvant therapy with imatinib after resection of small
gastric GISTs needed further investigation.
In summary, endoscopic resection of small gastric GISTs is safe
and feasible compared with surgical resection, although perforation
could not be totally avoided during and after resection. The clinical
outcome of endoscopic resection is also favorable.
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